Tak, P. P., Rigby, W., Rubbert-Roth, A., Peterfy, C., van Vollenhoven, R. F., Stohl, W., . . . Shaw, T. (2011). Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE. BMJ Group.
Chicago Style CitationTak, Paul P., et al. Sustained Inhibition of Progressive Joint Damage With Rituximab Plus Methotrexate in Early Active Rheumatoid Arthritis: 2-year Results From the Randomised Controlled Trial IMAGE. BMJ Group, 2011.
Cita MLATak, Paul P., et al. Sustained Inhibition of Progressive Joint Damage With Rituximab Plus Methotrexate in Early Active Rheumatoid Arthritis: 2-year Results From the Randomised Controlled Trial IMAGE. BMJ Group, 2011.